Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients

Tohoku Journal of Experimental Medicine

Volumn 222, Issue 2, 2010, Pages 105-112

  Mauri, Tommaso ^a,b   Masson, Serge ^c   Pradella, Andrea ^a,b   Bellani, Giacomo ^a,b   Coppadoro, Andrea ^a,b   Bombino, Michela ^b   Valentino, Sonia ^d   Patroniti, Nicolo' ^a,b   Mantovani, Alberto ^d,e   Pesenti, Antonio ^a,b   Latini, Roberto ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Acute lung injury acute respiratory distress syndrome; Marker; Pentraxin 3; Severity; Soluble receptor for advanced glycation endproducts

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG ALVEOLUS; LUNG INFECTION; LUNG LAVAGE; MALE; OXYGENATION; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY ALVEOLI; RECEPTORS, IMMUNOLOGIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; SERUM AMYLOID P-COMPONENT; SEVERITY OF ILLNESS INDEX;

EID: 77958093962     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.222.105     Document Type: Article

References (25)

1. Bernard, G.R., Artigas, A., Brigham, K.L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, JR., Morris, A. & Spragg, R. (1994) The American-European Consensus Conference on ARDS: definitions, mechanism, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med., 149, 818-824.
2. Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., Schein, R.M. & Sibbald, W.J. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101, 1644-1655.
3. Bottazzi, B., Garlanda, C., Cotena, A., Moalli, F., Jaillon, S., Deban, L. & Mantovani, A. (2009) The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol. Rev., 227, 9-18.
4. Briot, R., Frank, J.A., Uchida, T., Lee, J.W., Calfee, C.S. & Matthay, M.A. (2009) Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fuid clearance in isolated per fused human lungs. Chest, 135, 269-275.
5. Calfee, C.S., Ware, L.B., Eisner, M.D., Parsons, P.E., Thompson, B.T., Wickersham, N. & Matthay, M.A.; NHLBI ARDS Network. (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax, 63, 1083-1089.
6. Chen, C.M., Chou, H.C., Wang, L.F. & Lang, Y.D. (2008) Capto-pril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury. Crit. Care Med., 36, 1880-1885.
7. Chen, C.Y., Yang, K.Y., Chen, M.Y., Chen, H.Y., Lin, M.T., Lee, Y.C., Perng, R.P., Hsieh, S.L., Yang, P.C. & Chou, T.Y. (2009) Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med., 180, 751-760.
8. Frank, J.A., Parsons, P.E. & Matthay, M.A. (2006) Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest, 130, 1906-1914.
9. He, X., Han, B., Bai, X., Zhang, Y., Cypel, M., Mura, M., Keshavjee, S. & Liu, M. (2010) PTX3 as a potential biomark-er of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med., 36, 356-364.
10. Hirakata, Y., Yano, H., Arai, K., Endo, S., Kanamori, H., Aoyagi, T., Hirotani, A., Kitagawa, M., Hatta, M., Yamamoto, N., Kunishima, H., Kawakami, K. & Kaku, M. (2010) Monolayer culture systems with respiratory epithelial cells for evaluation of bacterial invasiveness. Tohoku J. Exp. Med., 220, 15-19.
11. Latini, R., Maggioni, A.P., Peri, G., Gonzini, L., Lucci, D., Mocarelli, P., Vago, L., Pasqualini, F., Signorini, S., Soldateschi, D., Tarli, L., Schweiger, C., Fresco, C., Cecere, R., Tognoni, G. & Mantovani, A.; Lipid Assessment Trial Italian Network (LATIN) Investigators. (2004) Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation, 110, 2349-2354.
12. Mauri, T., Bellani, G., Patroniti, N., Coppadoro, A., Peri, G., Cuccovillo, I., Cugno, M., Iapichino, G., Gattinoni, L., Pesenti, A. & Mantovani, A. (2010a) Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med., 36, 621-629.
13. Mauri, T., Berra, L., Kumwilaisak, K., Pivi, S., Ufberg, J.W., Kueppers, F., Pesenti, A. & Bigatello, L.M. (2010b) Lateral-horizontal patient position and horizontal orientation of the endotracheal tube to prevent aspiration in adult surgical intensive care unit patients: a feasibility study. Respir. Care, 55, 294-302.
14. Mauri, T., Coppadoro, A., Bellani, G., Bombino, M., Patroniti, N., Peri, G., Mantovani, A. & Pesenti, A. (2008) Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity. Crit. Care Med., 36, 2302-2308.
15. Mukherjee, T.K., Mukhopadhyay, S. & Hoidal, J.R. (2008) Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir. Physiol. Neurobiol., 162, 210-215.
16. Murray, J.F., Matthay, M.A., Luce, J.M. & Flick, M.R. (1988) An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 138, 720-723.
17. Ramasamy, R., Yan, S.F. & Schmidt, A.M. (2009) RAGE: therapeutic target and biomarker of the inflammatory response - the evidence mounts. J. Leukoc. Biol., 86, 505-512.
18. Sarge, T. & Talmor, D. (2009) Targeting transpulmonary pressure to prevent ventilator induced lung injury. Minerva Anestesiol., 75, 293-299.
19. Schmidt, A.M., Hori, O., Brett, J., Yan, S.D., Wautier, J.L. & Stern, D. (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterio-scler. Thromb., 14, 1521-1528.
20. Su, X., Looney, M.R., Gupta, N. & Matthay, M.A. (2009) Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am. J. Physiol. Lung. Cell. Mol. Physiol., 297, L1-L5.
21. The Acute Respiratory Distress Syndrome Network. (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New Engl. J. Med., 342, 1301-1308.
22. Uchida, T., Shirasawa, M., Ware, L.B., Kojima, K., Hata, Y., Makita, K., Mednick, G., Matthay, Z.A. & Matthay, M.A. (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med., 173, 1008-1015.
23. van Zoelen, M.A., Schmidt, A.M., Florquin, S., Meijers, J.C., de Beer, R., de Vos, A.F., Nawroth, P.P., Bierhaus, A. & van der Poll, T. (2009) Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J. Infect. Dis., 200, 765-773.
24. Vincent, J.L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C.K., Suter, P.M. & Thijs, L.G. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med., 22, 707-710.
25. Yan, S.F., Ramasamy, R. & Schmidt, A.M. (2009) Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J. Mol. Med., 87, 235-247.